Skip to main content
. 2020 Sep 29;15:268. doi: 10.1186/s13023-020-01525-2

Fig. 6.

Fig. 6

Clinical Trial Endpoints. Overview of established hematologic response criteria and target organs to measure responses to treatment in relation to established objective endpoints and the identified need for novel endpoints to enable early and robust trial readouts